Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol in Parkinson's Disease with GBA Mutation (GREAT)
NCT05830396Phase 3Unknown
- Sponsor
- University Medical Center Groningen
- Start
- May 2023
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in Parkinson's disease (PD), sponsored by University Medical Center Groningen. Status: unknown.
02
Drugs
ambroxol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05830396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05830396.